In summary, our data show that the inhibition of the de novo pyrimidine biosynthesis by targeting the enzymatic activity of DHODH leads to efficient inhibition of rRNA production and nucleolar stress and therefore, decreases proliferation specifically in glioblastoma cells. This evidence concerns the gene DHODH and glioblastoma.